A Randomized Trial of Inhaled Nitric Oxide to Prevent Ischemia-Reperfusion Injury after Lung Transplantation

American Journal of Respiratory and Critical Care Medicine

Volumn 167, Issue 11, 2003, Pages 1483-1489

  Meade, Maureen O ^b   Granton, John T ^a   Matte Martyn, Andrea ^b   McRae, Karen ^b   Weaver, Bruce ^b   Cripps, Paula ^b   Keshavjee, Shaf H ^b  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b NONE

Author keywords

Critical care; Lung transplantation; Mechanical ventilation; Nitric oxide

Indexed keywords

NITRIC OXIDE; NITROGEN; VASODILATOR AGENT;

ADULT; AGE; ARTERIAL OXYGEN TENSION; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXTUBATION; FEMALE; GENDER; HEMODYNAMICS; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LUNG DISEASE; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; INHALATIONAL DRUG ADMINISTRATION; POSTOPERATIVE COMPLICATION; REPERFUSION; TIME;

ADMINISTRATION, INHALATION; ADULT; FEMALE; HUMANS; INTENSIVE CARE UNITS; LUNG TRANSPLANTATION; MALE; NITRIC OXIDE; POSTOPERATIVE COMPLICATIONS; REPERFUSION; REPERFUSION INJURY; RESPIRATION, ARTIFICIAL; TIME FACTORS; VASODILATOR AGENTS;

EID: 0038132109     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.2203034     Document Type: Article

References (49)

1. King RC, Binns OA, Rodriguez F, Kanithanon RC, Daniel TM, Spotnitz WD, Tribble CG, Kron IL. Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation. Ann Thorac Surg 2000;69:1681-1685.
2. Bando K, Paradis IL, Similo S, Konishi H, Komatsu K, Zullo TG, Yousem SA, Close JM, Zeevi A, Duquesnoy RJ, et al. Obliterative bronchiolitis after lung and heart-lung transplantation: an analysis of risk factors and management. J Thorac Cardiovasc Surg 1995;110:4-14.
3. Fiser SM, Tribble CG, Long SM, Kaza AK, Kern JA, Jones DR, Robbins MK, Kron IL. Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome. Ann Thorac Surg 2002;73:1041-1048.
4. Fiser SM, Tribble CG, Long SM, Kaza AK, Cope JT, Laubach VE, Kern JA, Kron IL. Lung transplant reperfusion injury involves pulmonary macrophages and circulating leukocytes in a biphasic response. J Thorac Cardiovasc Surg 2001;121:1069-1075.
5. Karamsetty MR, Klinger JR. NO: more than just a vasodilator in lung transplantation. Am J Respir Cell Mol Biol 2002;26:1-5.
6. Minamoto K, Pinsky DJ, Fujita T, Naka Y. Timing of nitric oxide donor supplementation determines endothelin-1 regulation and quality of lung preservation for transplantation. Am J Respir Cell Mol Biol 2002; 26:14-21.
7. Shiraishi T, Kuroiwa A, Shirakusa T, Kawahara K, Yoneda S, Kitano K, Okabayashi K, Iwasaki A. Free radical-mediated tissue injury in acute lung allograft rejection and the effect of superoxide dismutase. Ann Thorac Surg 1997;64:821-825.
8. Meyer KC, Love RB, Zimmerman JJ. The therapeutic potential of nitric oxide in lung transplantation. Chest 1998;113:1360-1371.
9. Lindberg L, Sjoberg T, Ingemansson R, Steen S. Inhalation of nitric oxide after lung transplantation. Ann Thorac Surg 1996;61:956-962.
10. Adatia I, Lillehei C, Arnold JH, Thompson JE, Palazzo R, Fackler JC, Wessel DL. Inhaled nitric oxide in the treatment of postoperative graft dysfunction after lung transplantation. Ann Thorac Surg 1994;57: 1311-1318.
11. Macdonald P, Mundy J, Rogers P, Harrison G, Branch J, Glanville A, Keogh A, Spratt P. Successful treatment of life-threatening acute reperfusion injury after lung transplantation with inhaled nitric oxide. J Thorac Cardiovasc Surg 1995;110:861-863.
12. Pinsky DJ, Naka Y, Chowdhury NC, Liao H, Oz MC, Michler RE, Kubaszewski E, Malinski T, Stern DM. The nitric oxide/cyclic GMP pathway in organ transplantation: critical role in successful lung preservation. Proc Natl Acad Sci USA 1994;91:12086-12090.
13. Liu M, Tremblay L, Cassivi SD, Bai XH, Mourgeon E, Pierre AF, Slutsky AS, Post M, Keshavjee S. Alterations of nitric oxide synthase expression and activity during rat lung transplantation. Am J Physiol Lung Cell Mol Physiol 2000;278:L1071-L1081.
14. Lu YT, Liu SF, Mitchell JA, Malik AB, Hellewell PG, Evans TW. The role of endogenous nitric oxide in modulating ischemia-reperfusion injury in the isolated, blood-perfused rat lung. Am J Respir Crit Care Med 1998;157:273-279.
15. Schutte H, Witzenrath M, Mayer K, Rosseau S, Seeger W, Grimminger F. Short-term "preconditioning" with inhaled nitric oxide protects rabbit lungs against ischemia-reperfusion injury. Transplantation 2001; 72:1363-1370.
16. Tagawa T, Suda T, Daddi N, Kozower BD, Kanaan SA, Mohanakumar T, Patterson GA. Low-dose endobronchial gene transfer to ameliorate lung graft ischemia-reperfusion injury. J Thorac Cardiovasc Surg 2002; 123:795-802.
17. Thabut G, Brugiere O, Leseche G, Stern JB, Fradj K, Herve P, Jebrak G, Marty J, Fournier M, Mal H. Preventive effect of inhaled nitric oxide and pentoxifylline on ischemia/reperfusion injury after lung transplantation. Transplantation 2001;71:1295-1300.
18. Schutte H, Witzenrath M, Mayer K, Weissmann N, Schell A, Rosseau S, Seeger W, Grimminger F. The PDE inhibitor zaprinast enhances NO-mediated protection against vascular leakage in reperfused lungs. Am J Physiol Lung Cell Mol Physiol 2000;279:L496-L502.
19. Kawashima M, Bando T, Nakamura T, Isowa N, Liu M, Toyokuni S, Hitomi S, Wada H. Cytoprotective effects of nitroglycerin in ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med 2000;161: 935-943.
20. King RC, Binns OA, Kanithanon RC, Cope JT, Chun RL, Shockey KS, Tribble CG, Kron IL. Low-dose sodium nitroprusside reduces pulmonary reperfusion injury. Ann Thorac Surg 1997;63:1398-1404.
21. Bhabra MS, Hopkinson DN, Shaw TE, Hooper TL. Attenuation of lung graft reperfusion injury by a nitric oxide donor. J Thorac Cardiovasc Surg 1997;13:327-334.
22. Bhabra MS, Hopkinson DN, Shaw TE, Hooper TL. Low-dose nitric oxide inhalation during initial reperfusion enhances rat lung graft function. Ann Thorac Surg 1997;63:339-344.
23. Bacha EA, Sellak H, Murakami S, Mazmanian GM, Detruit H, de Montpreville V, Chapelier AR, Libert JM, Dartevelle PG, Herve P. Inhaled nitric oxide attenuates reperfusion injury in non-heartbeating-donor lung transplantation: Paris-Sud University Lung Transplantation Group. Transplantation 1997;63:1380-1386.
24. Fujino S, Nagahiro I, Triantafillou AN, Boasquevisque CH, Yano M, Cooper JD, Patterson GA. Inhaled nitric oxide at the time of harvest improves early lung allograft function. Ann Thorac Surg 1997; 63:1383-1390.
25. Bacha EA, Herve P, Murakami S, Chapelier A, Mazmanian GM, de Montpreville V, Detruit H, Libert JM, Dartevelle P. Lasting beneficial effect of short-term inhaled nitric oxide on graft function after lung transplantation: Paris-Sud University Lung Transplantation Group. J Thorac Cardiovasc Surg 1996;112:590-598.
26. Yamashita M, Schmid RA, Ando K, Cooper JD, Patterson GA. Nitroprusside ameliorates lung allograft reperfusion injury. Ann Thorac Surg 1996;62:791-797.
27. Okabayashi K, Triantafillou AN, Yamashita M, Aoe M, DeMeester SR, Cooper JD, Patterson GA. Inhaled nitric oxide improves lung allograft function after prolonged storage. J Thorac Cardiovasc Surg 1996;112: 293-299.
28. Eppinger MJ, Ward PA, Jones ML, Bolling SF, Deeb GM. Disparate effects of nitric oxide on lung ischemia-reperfusion injury. Ann Thorac Surg 1995;60:1169-1176.
29. Naka Y, Chowdhury NC, Liao H, Roy DK, Oz MC, Michler RE, Pinsky DJ. Enhanced preservation of orthotopically transplanted rat lungs by nitroglycerin but not hydralazine: requirement for graft vascular homeostasis beyond harvest vasodilation. Circ Res 1995;76:900-906.
30. Lindemann S, Sharafi M, Spiecker M, Buerke M, Fisch A, Grosser T, Veit K, Gierer C, Ibe W, Meyer J, et al. NO reduces PMN adhesion to human vascular endothelial cells due to downregulation of ICAM-1 mRNA and surface expression. Thromb Res 2000;97:113-123.
31. Lefer DJ, Jones SP, Girod WG, Baines A, Grisham MB, Cockrell AS, Huang PL, Scalia R. Leukocyte-endothelial cell interactions in nitric oxide synthase-deficient mice. Am J Physiol 1999;276:H1943-H1950.
32. Howlett CE, Hutchison JS, Veinot JP, Chiu A, Merchant P, Fliss H. Inhaled nitric oxide protects against hyperoxia-induced apoptosis in rat lungs. Am J Physiol 1999;277:L596-L605.
33. Ardehali A, Laks H, Levine M, Shpiner R, Ross D, Watson LD, Shvartz O, Sangwan S, Waters PF. A prospective trial of inhaled nitric oxide in clinical lung transplantation. Transplantation 2001;72:112-115.
34. McQuitty CK. Con: inhaled nitric oxide should not be used routinely in patients undergoing lung transplantation. J Cardiothorac Vasc Anesth 2001;15:790-792.
35. Szabolcs MJ, Ravalli S, Minanov O, Sciacca RR, Michler RE, Cannon PJ. Apoptosis and increased expression of inducible nitric oxide synthase in human allograft rejection. Transplantation 1998;65:804-812.
36. Worrall NK, Boasquevisque CH, Misko TP, Sullivan PM, Ferguson TB Jr, Patterson GA. Inducible nitric oxide synthase is expressed during experimental acute lung allograft rejection. J Heart Lung Transplant 1997;16:334-339.
37. Worrall NK, Boasquevisque CH, Botney MD, Misko TP, Sullivan PM, Ritter JH, Ferguson TB Jr, Patterson GA. Inhibition of inducible nitric oxide synthase ameliorates functional and histological changes of acute lung allograft rejection. Transplantation 1997;63:1095-1101.
38. Laroux FS, Lefer DJ, Kawachi S, Scalia R, Cockrell AS, Gray L, Van der Heyde H, Hoffman JM, Grisham MB. Role of nitric oxide in the regulation of acute and chronic inflammation. Antioxid Redox Signal 2000;2:391-396.
39. Laroux FS, Pavlick KP, Hines IN, Kawachi S, Harada H, Bharwani S, Hoffman JM, Grisham MB. Role of nitric oxide in inflammation. Acta Physiol Scand 2001;173:113-118.
40. Moncada S, Higgs EA. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 1995;9:1319-1330.
41. Murakami S, Bacha EA, Mazmanian GM, Detruit H, Chapelier A, Dartevelle P, Herve P. Effects of various timings and concentrations of inhaled nitric oxide in lung ischemia-reperfusion: The Paris-Sud University Lung Transplantation Group. Am J Respir Crit Care Med 1997; 156:454-458.
42. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome: The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000;342:1301-1308.
43. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 1995;23:1638-1652.
44. Ely EW, Baker AM, Dunagan DP, Burke HL, Smith AC, Kelly PT, Johnson MM, Browder RW, Bowton DL, Haponik EF. Effect on the duration of mechanical ventilation of identifying patients capable of breathing spontaneously. N Engl J Med 1996;335:1864-1869.
45. Hosenpud JD, Bennett LE, Keck BM, Boucek MM, Novick RJ. The registry of the International Society for Heart and Lung Transplantation: eighteenth official report: 2001. J Heart Lung Transplant 2001;20: 805-815.
46. Date H, Triantafillou AN, Trulock EP, Pohl MS, Cooper JD, Patterson GA. Inhaled nitric oxide reduces human lung allograft dysfunction. J Thorac Cardiovasc Surg 1996;111:913-919.
47. Luh SP, Tsai CC, Shau WY, Shiau SY, Jan IS, Kuo SH, Yang PC. Protective effects of inhaled nitric oxide and gabexate mesilate in lung reperfusion injury after transplantation from non-heart-beat donors. J Heart Lung Transplant 2002;21:251-259.
48. Murakami S, Bacha EA, Herve P, Detruit H, Chapelier AR, Dartevelle PG, Mazmanian GM. Prevention of reperfusion injury by inhaled nitric oxide in lungs harvested from non-heart-beating donors: Paris-Sud University Lung Transplantation Group. Ann Thorac Surg 1996; 62:1632-1638.
49. Struber M, Harringer W, Ernst M, Morschheuser T, Hein M, Bund M, Haverich A. Inhaled nitric oxide as a prophylactic treatment against reperfusion injury of the lung. Thorac Cardiovasc Surg 1999;47:179-182.